http://orcid.org/0000-0001-8687-5120
Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mansi Bhurani, Lorenz Admojo, Carrie Van Der Weyden, Robert Twigger, Ali Bazargan, Hang Quach, Allan Zimet, Luke Coyle, Julian Lindsay, Dejan Radeski, Eliza Hawkes, Glen Kennedy, Ian Irving, Naadir Gutta, Judith Trotman, James Yeung, Lindsay Dunlop, Minh Hua, Pratyush Giri, Sam Yuen, Shyam Panicker, Susan Moreton, Liane Khoo, Ashleigh Scott, David Kipp, Andrew McQuillan, Chris McCormack, Michael Dickinson & Henry Miles Prince. (2021) Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study. Leukemia & Lymphoma 62:2, pages 330-336.
Read now
Read now
Carrie van der Weyden, Sean Harrop & Henry Miles Prince. (2020) Pralatrexate and angioimmunoblastic T-cell lymphoma: time for a second look?. Leukemia & Lymphoma 61:9, pages 2031-2033.
Read now
Read now
Articles from other publishers (4)
Sharina C. Macapagal & N. Nora Bennani. (2023) Nodal peripheral T-cell lymphoma: Chemotherapy-free management, are we there yet?. Blood Reviews 60, pages 101071.
Crossref
Crossref
Jun Du, Shikai Jin, Minghui Zhang, Xuehang Fu, Jingwen Yang, Liwen Zhang, Zhenwei Chen, Zoufang Huang, Weisong Li, Jian Hou & Ting Wang. (2023) Precise diagnosis and targeted therapy of nodal T-follicular helper cell lymphoma (T-FHCL). Frontiers in Oncology 13.
Crossref
Crossref
Zachary Braunstein, Miguel Ruiz, Walter Hanel, Polina Shindiapina, John C. Reneau & Jonathan E. Brammer. (2022) Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas. Journal of Personalized Medicine 12:6, pages 964.
Crossref
Crossref
Aydan AKDENİZ, Nurcan YILMAZ, Mahmut Bakır KOYUNCU & Anıl TOMBAK. (2022) Outcome in patients with peripheral T-cell lymphoma treated with pralatrexate, single center experience. Turkish Journal of Internal Medicine 4:1, pages 20-24.
Crossref
Crossref